Evaluation of a novel medical device for pegfilgrastim administration
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Science"
DOI: 10.1111/cas.15335
Abstract: Pegfilgrastim, a pegylated form of granulocyte colony‐stimulating factor, has reduced the risk of developing febrile neutropenia, which is associated with an increase in severe infection and prolonged hospitalization. However, pegfilgrastim administration requires that patients visit… read more here.
Keywords: administration; pegfilgrastim administration; chemotherapy; study ... See more keywords